Epstein Secrets

he election after the voting, and we still don't know the winners [in] of those races." McEnany added, "19 percent of ballots have been rejected in Queens, 28 percent rejected in Brooklyn. There are questions about mass mail-in voting. And I know you don't want to hear them, which is why you talk over

ll guard against any pressure that comes from the FDA to lower its standards or to approve something that you know doesn't meet the standards." Dr. Macaya Douoguih, Janssen Vaccines Clinical Development & Medical Affairs: "We are working around the clock to accelerate our development, but we're not cutting corn

the election after the voting, and we still don't know the winners [in] of those races." McEnany added, "19 percent of ballots have been rejected in Queens, 28 percent rejected in Brooklyn. There are questions about mass mail-in voting. And I know you don't want to hear them, which is why you talk over

ll guard against any pressure that comes from the FDA to lower its standards or to approve something that you know doesn't meet the standards." Dr. Macaya Douoguih, Janssen Vaccines Clinical Development & Medical Affairs: "We are working around the clock to accelerate our development, but we're not cutting corn

he election after the voting, and we still don't know the winners [in] of those races." McEnany added, "19 percent of ballots have been rejected in Queens, 28 percent rejected in Brooklyn. There are questions about mass mail-in voting. And I know you don't want to hear them, which is why you talk over

ll guard against any pressure that comes from the FDA to lower its standards or to approve something that you know doesn't meet the standards." Dr. Macaya Douoguih, Janssen Vaccines Clinical Development & Medical Affairs: "We are working around the clock to accelerate our development, but we're not cutting cor

he election after the voting, and we still don't know the winners [in] of those races." McEnany added, "19 percent of ballots have been rejected in Queens, 28 percent rejected in Brooklyn. There are questions about mass mail-in voting. And I know you don't want to hear them, which is why you talk over

ll guard against any pressure that comes from the FDA to lower its standards or to approve something that you know doesn't meet the standards." Dr. Macaya Douoguih, Janssen Vaccines Clinical Development & Medical Affairs: "We are working around the clock to accelerate our development, but we're not cutting cor